The Justice Department said Walgreens will pay $209.2 million to resolve claims it improperly billed Medicare, Medicaid and other federal programs for unnecessarily dispensing hundreds of thousands of insulin pens, and $60 million to resolve claims it overbilled Medicaid by concealing lower drug prices it offered the public through a discount program.

(Reporting by Jonathan Stempel in New York; Editing by David Gregorio)